Sepsis Diagnostics Market Size & Trends | Industry Growth, 2028

Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology [Molecular Diagnostics (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarray), Flow Cytometry, Microfluidics, Immunoassay, Biomarker, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

Publication Month: May 2022 | Report Code: TIPHE100001391 | No. of Pages: 267 | Category: Medical Device | Status: Published

The sepsis diagnostics market is projected to reach US$ 1,226.52 million by 2028 from US$ 661.83 million in 2021; it is expected to grow at a CAGR of 9.2% from 2021 to 2028.


Factors such as the surging incidence of sepsis due to increasing nosocomial infections and rising demand for rapid diagnostic tests leading to increasing product launches drive the sepsis diagnostics market growth.

Sepsis is a serious and life-threatening clinical condition that generally results from primary bacterial infection or, less frequently, from a fungal and/or viral infection. Three stages of sepsis are sepsis, severe sepsis, and the final stage of septic shock. Sepsis diagnostics is the study of diagnosis of this condition.

North America is likely to dominate the sepsis diagnostics market during the forecast period. The US held the largest share of the North American market in 2021 and is expected to continue this trend during the forecast period. Sepsis affects significant patient populations in hospitals and is the sixth most common reason for hospitalization. Increasing prevalence of sepsis and surging investments in the research and development of sepsis diagnosis are projected to accelerate the sepsis diagnostics market growth in the region. Moreover, the presence of large healthcare market players results in the growing sepsis diagnostics product launches.

The sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The sepsis diagnostics report offers insights and in-depth analysis of the market, emphasizing parameters such as market trends, technological advancements, market dynamics, and the competitive analysis of the globally leading market players.

Strategic Insights

Lucrative Regions for Sepsis Diagnostics Market

Lucrative Regions for Sepsis Diagnostics Market

Get more information on this report :


Market Insights

High Incidence of Sepsis due to Increasing Nosocomial Infections

Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and suffering from AIDS and chronic illnesses like diabetes. Hospital-acquired infections, also known as nosocomial infections, are the primary cause of morbidity and mortality among hospitalized patients. According to the "2020 National and State Healthcare-Associated Infections Progress Report" published by the Centers for Disease Control and Prevention (CDC) in 2021, about 24%, 35%, and 15% increase was recorded in central line-associated bloodstream infections, ventilator-associated events, and Methicillin-resistant Staphylococcus Aureus (MRSA) bacteremia, respectively, in the US between 2019 and 2020. Thus, the rising bloodstream infections will increase the adoption of sepsis diagnostic products.

In September 2020, World Health Organization (WHO) estimated that each year almost 50% cases of sepsis are seen among children, and 2.9 million deaths occurred in children. Most deaths can be prevented through early diagnosis and appropriate clinical management. Thus, the high incidence rate of sepsis boosts the demand for sepsis diagnostic products, thereby supporting the sepsis diagnostics market growth.

Product Insights

Based on product, the global sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. In 2021, the blood culture media segment held the largest share of the market. According to the Journal of the Academy of Clinical Microbiologists report, blood culture media remains one of the most critical investigations in the sepsis management as it allows identification of the responsible organism for sepsis, appropriate choice of empirical and specific antibiotics, and points towards further investigations for identifying the focus on infection. A blood culture media is recommended for all septic patients. However, the software segment is anticipated to register the highest CAGR in the market during the forecast period.

Sepsis Diagnostics Market, by Product – 2021 and 2028

Sepsis Diagnostics Market, by Product – 2021 and 2028

Get more information on this report :


Technology Insights

Based on technology, the global sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. In 2021, the microbiology segment held the largest share of the market. Rapid and specific pathogen identification is important for sepsis treatment, and microbiological techniques act as the gold standard for sepsis pathogen identification that can be done through blood culture followed by sub culturing and pathogen identification through biochemical or microscopic means. However, the molecular diagnostics segment is expected to register the highest CAGR in the market during forecast period.

Method Insights

Based on method, the global sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. In 2021, the conventional diagnostics segment held a larger share of the market. However, the automated diagnostics segment is expected to register a higher CAGR in the market during forecast period. Conventional diagnostics procedure for sepsis takes a few days. Thus, conventional diagnostics method is slowly adopted than automated diagnostics. Also, companies focus on developing automated diagnostics based on advanced technologies, such as molecular diagnostics for detecting sepsis.

Test Type Insights

Based on test type, the global sepsis diagnostics market is segmented into point-of-care tests and laboratory tests. In 2021, the laboratory tests segment held a larger share of the market. However, the point-of-care tests segment is expected to register a higher CAGR in the market during forecast period. POC platforms can lead to timely intervention with appropriate therapeutics as it simplifies the needs of the diagnostics process by offering accessible and affordable clinical information to detect sepsis at a much earlier stage.

Pathogen Insights

Based on pathogen, the global sepsis diagnostics market is segmented into bacteria sepsis, fungal sepsis, and others. In 2021, the bacteria sepsis segment held the largest market share. Moreover, the same segment is expected to register the highest CAGR in the market during forecast period.

End User Insights

Based on end user, the global sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. In 2021, the hospitals segment held the largest share of the market. However, the pathology and reference laboratories segment is expected to register the highest CAGR in the market during forecast period.

Product launches and collaborations are highly adopted strategies by the global sepsis diagnostics market players to expand their global footprints and product portfolios. The players also focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally. They aim to flourish their market shares with the development of innovative products. A few of the recent key market developments are listed below:

In November 2021, T2 Biosystems, Inc. executed territory exclusive distribution agreement in Taiwan. Under the terms of the agreement, T2 Biosystems will sell T2Dx Instruments, along with T2Bacteria, T2Candida, and T2Resistance Panels through its distributor. T2 Biosystems and its new distribution partner are collaborated with the health authorities in Taiwan to gain regulatory approval and offer the highest quality sepsis care to patients.

In May 2019, Danaher subsidiary Beckman Coulter launched Access PCT assay. The state-of-the-art sensitivity and low-end precision of Access PCT assay combined with short incubation time help physicians in the risk assessment of critically ill patients in danger of progression to severe sepsis or septic shock, with test results available in under 20 minutes. The new Access PCT assay received CE mark certification and available for use on the Access Family of Immunoassay Systems, including the Access 2, UniCel DxI 600, and UniCel DxI 800.

Sepsis Diagnostics – Market Segmentation

The global sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, and end user. In terms of product, the global sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. Based on technology, the sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. In terms of method, the market is segmented into automated diagnostics and conventional diagnostics. Based on test type, the global sepsis diagnostics market is segmented into point-of-care tests and laboratory tests. In terms of pathogen, the market is segmented into bacteria sepsis, fungal sepsis, and others. In terms of end user, the sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others.

Company profile

  • Abbott
  • F. HOFFMANN-LA ROCHE LTD.
  • Immunexpress Inc.
  • BD
  • Danaher
  • Luminex Corporation
  • Thermo Fisher Scientific Inc.
  • bioMerieux SA.
  • T2 Biosystems, Inc.
  • Axis-Shield Diagnostics Ltd.

Frequently Asked Questions

The Centers for Disease Control and Prevention (CDC) defines sepsis as the body's extreme response to an infection. It is a life-threatening medical emergency. Sepsis can also be a result of other infections, including viral infections, such as COVID-19 or influenza. Early detection and specific clinical intervention has revealed to be crucial for improving the outcome of patients suffering from sepsis.
The factors that are driving the growth of market are high incidence of sepsis due to nosocomial infections and the high demand for rapid diagnostic tests leading to increasing product launches. However, the lack of skilled professionals is the major factor hindering the sepsis diagnostics market growth.
The sepsis diagnostics market majorly consists of the players, such as Abbott; F. Hoffman-La Roche Ltd; Immunexpress Inc.; BD; Danaher (Beckman Coulter); Luminex Corporation; Thermo Fischer Scientific Inc.; bioMerieux SA; T2 Biosystems, Inc.; Axis-Shield Diagnostics Ltd; among others.
The market is estimated to grow at a CAGR of 9.2% during the forecast period.
The sepsis diagnostics market is estimated to be valued at US$ 661.83 million in 2021.
The sepsis diagnostics market is expected to be valued at US$ 1,226.52 million in 2028
The sepsis diagnostics market is analyzed in the basis of product, technology, method, test type, pathogen, and end user. Based on technology, the market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest share of the market. However, the molecular diagnostics segment is anticipated to register the highest CAGR.
North America accounts for the major market share of sepsis diagnostics market in 2021 owing to rising number of product launches and approvals.
Asia Pacific is expected to be the fastest growing region in sepsis diagnostics market over the forecast period.

1.Introduction

1.1.Scope of the Study

1.2.The Insight Partners Research Report Guidance

1.3.Market Segmentation

1.3.1.Global Sepsis Diagnostics Market – By Product

1.3.2.Global Sepsis Diagnostics Market – By Technology

1.3.3.Global Sepsis Diagnostics Market – By Method

1.3.4.Global Sepsis Diagnostics Market – By Test Type

1.3.5.Global Sepsis Diagnostics Market – By Pathogen

1.3.6.Global Sepsis Diagnostics Market – By End User

1.3.7.Global Sepsis Diagnostics Market – By Geography

2.Key Takeaways

3.Research Methodology

3.1.Coverage

3.2.Secondary Research

3.3.Primary Research

4.Sepsis Diagnostics Market – Market Landscape

4.1.Overview..

4.2.PEST Analysis..

4.2.1.North America PEST Analysis..

4.2.2.Europe PEST Analysis..

4.2.3.Asia Pacific PEST Analysis..

4.2.4.Middle East And Africa PEST Analysis..

4.2.5.South And Central America PEST Analysis..

4.3.Experts Opinion..

5.Sepsis Diagnostics Market – Key Market Dynamics..

5.1.Market Drivers..

5.1.1.High Incidence of Sepsis due to Increasing Nosocomial Infections..

5.1.2.Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches..

5.2.Market Restraints..

5.2.1.Lack of Skilled Professionals..

5.3.Market Opportunities..

5.3.1.Increase in Funding and Support for Sepsis Diagnostics Research..

5.4.Future Trends..

5.4.1.Rising Technological Advancements in Sepsis Diagnosis..

5.5.Impact Analysis..

6.Sepsis Diagnostics Market– Global Analysis..

6.1.Global Sepsis Diagnostics Market Revenue Forecast and Analysis..

6.2.Global Sepsis Diagnostics Market Revenue Forecast and Analysis..

6.3.Market Positioning of Key Players..

6.4.Global Sepsis Diagnostics market – Market Potential Analysis, By Region..

6.5.Comparative Company Analysis..

6.6.Growth Strategy Analysis..

6.7.PERFORMANCE OF KEY PLAYERS..

6.7.1.bioMérieux, Inc..

6.7.2.Danaher..

6.8.Market Share Analysis of Sepsis Diagnostics Market..

7.Global Sepsis Diagnostics Market Revenue and Forecasts To 2028– by Product..

7.1.Overview..

7.2.Global Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)..

7.3.Instruments..

7.3.1.Overview..

7.3.2.Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

7.4.Reagents and Assays..

7.4.1.Overview..

7.4.2.Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

7.5.Blood Culture Media..

7.5.1.Overview..

7.5.2.Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

7.6.Software..

7.6.1.Overview..

7.6.2.Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

8.Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Technology..

8.1.Overview..

8.2.Global Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)..

8.3.Molecular Diagnostics..

8.3.1.Overview..

8.3.2.Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

8.3.2.1.Polymerase Chain Reaction..

8.3.2.1.1.Overview..

8.3.2.1.2.Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

8.3.2.2.Peptide Nucleic Acid-Fluorescent in Situ Hybridization..

8.3.2.2.1.Overview..

8.3.2.2.2.Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

8.3.2.3.Syndromic Panel-Based Testing..

8.3.2.3.1.Overview..

8.3.2.3.2.Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

8.3.2.4.Microarrays..

8.3.2.4.1.Overview..

8.3.2.4.2.Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

8.4.Flow Cytometry..

8.4.1.Overview..

8.4.2.Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

8.5.Microfluidics..

8.5.1.Overview..

8.5.2.Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

8.6.Immunoassay..

8.6.1.Overview..

8.6.2.Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

8.7.Biomarkers..

8.7.1.Overview..

8.7.2.Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

8.8.Microbiology..

8.8.1.Overview..

8.8.2.Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

9.Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Method..

9.1.Overview..

9.2.Global Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)..

9.3.Automated Diagnostics..

9.3.1.Overview..

9.3.2.Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

9.4.Conventional Diagnostics..

9.4.1.Overview..

9.4.2.Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

10.Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Test Type..

10.1.Overview..

10.2.Global Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)..

10.3.Point-of-Care Tests..

10.3.1.Overview..

10.3.2.Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

10.4.Laboratory Tests..

10.4.1.Overview..

10.4.2.Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

11.Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Pathogen..

11.1.Overview..

11.2.Global Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)..

11.3.Bacterial Sepsis..

11.3.1.Overview..

11.3.2.Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

11.4.Fungal Sepsis..

11.4.1.Overview..

11.4.2.Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

11.5.Others..

11.5.1.Overview..

11.5.2.Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

12.Sepsis Diagnostics Market Revenue and Forecasts To 2028 – End User..

12.1.Overview..

12.2.Global Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)..

12.3.Hospitals..

12.3.1.Overview..

12.3.2.Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

12.4.Pathology and Reference Laboratories..

12.4.1.Overview..

12.4.2.Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

12.5.Others..

12.5.1.Overview..

12.5.2.Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)..

13.Global Sepsis Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis..

13.1.North America: Sepsis Diagnostics Market..

13.1.1.Overview..

13.1.2.North America: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.1.3.North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)..

13.1.4.North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)..

13.1.4.1.North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)..

13.1.5.North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)..

13.1.6.North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)..

13.1.7.North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)..

13.1.8.North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)..

13.1.9.North America: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)..

13.1.9.1.US: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.1.9.1.1.Overview..

13.1.9.1.2.US: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.1.9.1.3.US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)..

13.1.9.1.4.US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)..

13.1.9.1.4.1.US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)..

13.1.9.1.5.US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)..

13.1.9.1.6.US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)..

13.1.9.1.7.US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)..

13.1.9.1.8.US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)..

13.1.9.2.Canada: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.1.9.2.1.Overview..

13.1.9.2.2.Canada: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.1.9.2.3.Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)..

13.1.9.2.4.Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)..

13.1.9.2.4.1.Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)..

13.1.9.2.5.Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)..

13.1.9.2.6.Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)..

13.1.9.2.7.Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)..

13.1.9.2.8.Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)..

13.1.9.3.Mexico: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.1.9.3.1.Overview..

13.1.9.3.2.Mexico: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.1.9.3.3.Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)..

13.1.9.3.4.Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)..

13.1.9.3.4.1.Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)..

13.1.9.3.5.Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)..

13.1.9.3.6.Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)..

13.1.9.3.7.Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)..

13.1.9.3.8.Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)..

13.2.Europe: Sepsis Diagnostics Market..

13.2.1.Overview..

13.2.2.Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.2.3.Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)..

13.2.4.Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)..

13.2.4.1.Europe: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)..

13.2.5.Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)..

13.2.6.Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)..

13.2.7.Europe: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)..

13.2.8.Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)..

13.2.9.1.Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.1.1.Overview..

13.2.9.1.2.Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.1.3.Germany: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.1.4.Germany: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)..

13.2.9.1.4.1.Germany: Sepsis Diagnostics Market, by Molecular diagnostics– Revenue and Forecast to 2028 (US$ Million)..

13.2.9.1.5.Germany: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.1.6.Germany: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.1.7.Germany: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.1.8.Germany: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.2.France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.2.1.Overview..

13.2.9.2.2.France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.2.3.France: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.2.4.France: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)..

13.2.9.2.4.1.France: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.2.5.France: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.2.6.France: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.2.7.France: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.2.8.France: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.3.UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.3.1.Overview..

13.2.9.3.2.UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.3.3.UK: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.3.4.UK: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)..

13.2.9.3.4.1.UK: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)..

13.2.9.3.5.UK: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.3.6.UK: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.3.7.UK: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.3.8.UK: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.4.Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.4.1.Overview..

13.2.9.4.2.Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.4.3.Italy: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.4.4.Italy: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)..

13.2.9.4.4.1.Italy: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)..

13.2.9.4.5.Italy: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.4.6.Italy: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.4.7.Italy: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.4.8.Italy: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.5.Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.5.1.Overview..

13.2.9.5.2.Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.5.3.Spain: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.5.4.Spain: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)..

13.2.9.5.4.1.Spain: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)..

13.2.9.5.5.Spain: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.5.6.Spain: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.5.7.Spain: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)..

13.2.9.5.8.Spain: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.6.Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.6.1.Overview..

13.2.9.6.2.Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.6.3.Rest of Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.6.4.Rest of Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)..

13.2.9.6.4.1.Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)..

13.2.9.6.5.Rest of Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.6.6.Rest of Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.6.7.Rest of Europe: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)..

13.2.9.6.8.Rest of Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)..

13.3.Asia Pacific: Sepsis Diagnostics Market..

13.3.1.Overview..

13.3.2.Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)..

13.3.3.Asia Pacific: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)..

13.3.4.Asia Pacific: Sepsis Diagnostics Market, by Technology, 2019–2028 (USD Million)..

13.3.4.1.Asia Pacific Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)..

13.3.5.Asia Pacific: Sepsis Diagnostics Market, by Method, 2019–2028 (USD Million)..

13.3.6.Asia Pacific: Sepsis Diagnostics Market, by Test Type, 2019–2028 (USD Million)..

13.3.7.Asia Pacific: Sepsis Diagnostics Market, by Pathogen, 2019–2028 (USD Million)..

13.3.8.Asia Pacific: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)..

13.3.9.Asia Pacific: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)..

13.3.9.1.China: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)..

13.3.9.1.1.China: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)..

13.3.9.1.2.China: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)..

13.3.9.1.3.China: Sepsis Diagnostics Market, by Technology, 2019–2028 (USD Million)..

13.3.9.1.3.1.China Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)..

13.3.9.1.4.China: Sepsis Diagnostics Market, by Method, 2019–2028 (USD Million)..

13.3.9.1.5.China: Sepsis Diagnostics Market, by Test Type, 2019–2028 (USD Million)..

13.3.9.1.6.China: Sepsis Diagnostics Market, by Pathogen, 2019–2028 (USD Million)..

13.3.9.1.7.China: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)..

13.3.9.2.Japan: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)..

13.3.9.2.1.Japan: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)..

13.3.9.2.2.Japan: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)..

13.3.9.2.3.Japan: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)..

13.3.9.2.3.1.Japan Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)..

13.3.9.2.4.Japan: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)..

13.3.9.2.5.Japan: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)..

13.3.9.2.6.Japan: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)..

13.3.9.2.7.Japan: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)..

13.3.9.3.India: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)..

13.3.9.3.1.India: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)..

13.3.9.3.2.India: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)..

13.3.9.3.3.India: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)..

13.3.9.3.3.1.India Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)..

13.3.9.3.4.India: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)..

13.3.9.3.5.India: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)..

13.3.9.3.6.India: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)..

13.3.9.3.7.India: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)..

13.3.9.4.Australia: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)..

13.3.9.4.1.Australia: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)..

13.3.9.4.2.Australia: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)..

13.3.9.4.3.Australia: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)..

13.3.9.4.3.1.Australia Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)..

13.3.9.4.4.Australia: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)..

13.3.9.4.5.Australia: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)..

13.3.9.4.6.Australia: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)..

13.3.9.4.7.Australia: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)..

13.3.9.5.South Korea: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)..

13.3.9.5.1.South Korea: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)..

13.3.9.5.2.South Korea: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)..

13.3.9.5.3.South Korea: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)..

13.3.9.5.3.1.South Korea Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)..

13.3.9.5.4.South Korea: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)..

13.3.9.5.5.South Korea: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)..

13.3.9.5.6.South Korea: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)..

13.3.9.5.7.South Korea: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)..

13.3.9.6.Rest of Asia Pacific: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)..

13.3.9.6.1.Rest of Asia Pacific: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)..

13.3.9.6.2.Rest of Asia Pacific: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)..

13.3.9.6.3.Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)..

13.3.9.6.3.1.Rest of APAC Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)..

13.3.9.6.4.Rest of Asia Pacific: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)..

13.3.9.6.5.Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)..

13.3.9.6.6.Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)..

13.3.9.6.7.Rest of Asia Pacific: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)..

13.4.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts To 2028..

13.4.1.Overview..

13.4.2.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

13.4.3.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)..

13.4.4.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)..

13.4.4.1.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)..

13.4.5.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)..

13.4.6.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)..

13.4.7.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)..

13.4.8.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)..

13.4.9.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)..

13.4.9.1.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

13.4.9.1.1.Overview..

13.4.9.1.2.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

13.4.9.1.3.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)..

13.4.9.1.4.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)..

13.4.9.1.4.1.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)..

13.4.9.1.5.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)..

13.4.9.1.6.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)..

13.4.9.1.7.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)..

13.4.9.1.8.UAE: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)..

13.4.9.2.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

13.4.9.2.1.Overview..

13.4.9.2.2.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

13.4.9.2.3.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)..

13.4.9.2.4.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)..

13.4.9.2.4.1.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)..

13.4.9.2.5.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)..

13.4.9.2.6.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)..

13.4.9.2.7.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)..

13.4.9.2.8.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)..

13.4.9.3.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

13.4.9.3.1.Overview..

13.4.9.3.2.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

13.4.9.3.3.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)..

13.4.9.3.4.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)..

13.4.9.3.4.1.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)..

13.4.9.3.5.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)..

13.4.9.3.6.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)..

13.4.9.3.7.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)..

13.4.9.3.8.South Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)..

13.4.9.4.Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

13.4.9.4.1.Overview..

13.4.9.4.2.Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

13.4.9.4.3.Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)..

13.4.9.4.4.Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)..

13.4.9.4.4.1.Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)..

13.4.9.4.5.Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)..

13.4.9.4.6.Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)..

13.4.9.4.7.Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)..

13.4.9.4.8.Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)..

13.5.South And Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028..

13.5.1.Overview..

13.5.2.South and Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

13.5.3.South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)..

13.5.4.South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)..

13.5.4.1.South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)..

13.5.5.South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)..

13.5.6.South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)..

13.5.7.South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)..

13.5.8.South and Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)..

13.5.9.South and Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)..

13.5.9.1.Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

13.5.9.1.1.Overview..

13.5.9.1.2.Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

13.5.9.1.3.Brazil: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)..

13.5.9.1.4.Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)..

13.5.9.1.4.1.Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)..

13.5.9.1.5.Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)..

13.5.9.1.6.Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)..

13.5.9.1.7.Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)..

13.5.9.1.8.Brazil: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)..

13.5.9.2.Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

13.5.9.2.1.Overview..

13.5.9.2.2.Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)..

13.5.9.2.3.Argentina: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)..

13.5.9.2.4.Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)..

13.5.9.2.4.1.Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)..

13.5.9.2.5.Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)..

13.5.9.2.6.Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)..

13.5.9.2.7.Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)..

13.5.9.2.8.Argentina: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)..

13.5.9.3.Rest of South and Central America: Sepsis Diagnostics Market– Revenue and Forecast to 2028 (US$ Mn)..

13.5.9.3.1.Overview..

13.5.9.3.2.Rest of South and Central America: Sepsis Diagnostics Market– Revenue and Forecast to 2028 (US$ Mn)..

13.5.9.3.3.Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)..

13.5.9.3.4.Rest of South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)..

13.5.9.3.4.1.Rest of South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)..

13.5.9.3.5.Rest of South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)..

13.5.9.3.6.Rest of South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)..

13.5.9.3.7.Rest of South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)..

13.5.9.3.8.Rest of South and Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)..

14.Impact Of COVID-19 Pandemic..

14.1.North America: Impact Assessment of COVID-19 Pandemic..

14.2.Europe: Impact Assessment of COVID-19 Pandemic..

14.3.Asia-Pacific: Impact Assessment of COVID-19 Pandemic..

14.4.Middle East and Africa: Impact Assessment of COVID-19 Pandemic..

14.5.South and Central America: Impact Assessment of COVID-19 Pandemic..

15.Sepsis Diagnostics Market–Industry Landscape..

15.1.Overview..

15.2.Growth Strategies in the Sepsis Diagnostics Market (%)..

15.3.Organic Developments..

15.3.1.Overview..

15.4.Inorganic Developments..

15.4.1.Overview..

16.Company Profiles..

16.1.Abbott..

16.1.1.Key Facts..

16.1.2.Business Description..

16.1.3.Products and Services..

16.1.4.Financial Overview..

16.1.5.SWOT Analysis..

16.1.6.Key Developments..

16.2.F. HOFFMANN-LA ROCHE LTD..

16.2.1.Key Facts..

16.2.2.Business Description..

16.2.3.Products and Services..

16.2.4.Financial Overview..

16.2.5.SWOT Analysis..

16.2.6.Key Developments..

16.3.Immunexpress Inc..

16.3.1.Key Facts..

16.3.2.Business Description..

16.3.3.Products and Services..

16.3.4.Financial Overview..

16.3.5.SWOT Analysis..

16.3.6.Key Developments..

16.4.BD..

16.4.1.Key Facts..

16.4.2.Business Description..

16.4.3.Products and Services..

16.4.4.Financial Overview..

16.4.5.SWOT Analysis..

16.4.6.Key Developments..

16.5.Danaher (Beckman Coulter)..

16.5.1.Key Facts..

16.5.2.Business Description..

16.5.3.Products and Services..

16.5.4.Financial Overview..

16.5.5.SWOT Analysis..

16.5.6.Key Developments..

16.6.Luminex Corporation..

16.6.1.Key Facts..

16.6.2.Business Description..

16.6.3.Products and Services..

16.6.4.Financial Overview..

16.6.5.SWOT Analysis..

16.6.6.Key Developments..

16.7.THERMO FISHER SCIENTIFIC INC..

16.7.1.Key Facts..

16.7.2.Business Description..

16.7.3.Products and Services..

16.7.4.Financial Overview..

16.7.5.SWOT Analysis..

16.7.6.Key Developments..

16.8.bioMerieux SA..

16.8.1.Key Facts..

16.8.2.Business Description..

16.8.3.Products and Services..

16.8.4.Financial Overview..

16.8.5.SWOT Analysis..

16.8.6.Key Developments..

16.9.T2 Biosystems, Inc..

16.9.1.Key Facts..

16.9.2.Business Description..

16.9.3.Products and Services..

16.9.4.Financial Overview..

16.9.5.SWOT Analysis..

16.9.6.Key Developments..

16.10.Axis-Shield Diagnostics Ltd..

16.10.1.Key Facts..

16.10.2.Business Description..

16.10.3.Products and Services..

16.10.4.Financial Overview..

16.10.5.SWOT Analysis..

16.10.6.Key Developments..

17.Appendix..

17.1.About The Insight Partners..

17.2.Glossary of Terms..

LIST OF TABLES

Table 1.North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 2.North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 3.North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 4.North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million).

Table 5.North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 6.North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million).

Table 7.North America Sepsis Diagnostics Market, by End User– Revenue and Forecast to 2028 (US$ Million).

Table 8.US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million).

Table 9.US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 10.US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 11.US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 12.US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 13.US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 14.US Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 15.Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 16.Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 17.Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 18.Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 19.Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 20.Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 21.Canada Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 22.Mexico Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 23.Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 24.Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 25.Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 26.Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 27.Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 28.Mexico Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 29.Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 30.Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 31.Europe: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million).

Table 32.Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 33.Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 34.Europe: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)

Table 35.Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million).

Table 36.Germany: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 37.Germany: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 38.Germany: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 39.Germany: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 40.Germany: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 41.Germany: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million).

Table 42.Germany: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 43.France: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 44.France: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 45.France: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 46.France: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 47.France: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 48.France: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 49.France: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 50.UK: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 51.UK: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 52.UK: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 53.UK: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 54.UK: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 55.UK: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 56.UK: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 57.Italy: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 58.Italy: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 59.Italy: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 60.Italy: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 61.Italy: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 62.Italy: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)

Table 63.Italy: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 64.Spain: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 65.Spain: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 66.Spain: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 67.Spain: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 68.Spain: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 69.Spain: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 70.Spain: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 71.Rest of Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 72.Rest of Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 73.Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 74.Rest of Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 75.Rest of Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 76.Rest of Europe: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 77.Rest of Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 78.Asia Pacific: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 79.Asia Pacific: Sepsis Diagnostics Market, by Technology– Revenue and forecast to 2028 (USD Million)

Table 80.Asia Pacific: Sepsis Diagnostics Market, by Method– Revenue and forecast to 2028 (USD Million)

Table 81.Asia Pacific: Sepsis Diagnostics Market, by Test Type– Revenue and forecast to 2028 (USD Million)

Table 82.Asia Pacific: Sepsis Diagnostics Market, by Pathogen – Revenue and forecast to 2028 (USD Million).

Table 83.Asia Pacific: Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 84.China: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 85.China: Sepsis Diagnostics Market, by Technology– Revenue and forecast to 2028 (USD Million)

Table 86.China: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and forecast to 2028 (USD Million)

Table 87.China: Sepsis Diagnostics Market, by Method– Revenue and forecast to 2028 (USD Million)

Table 88.China: Sepsis Diagnostics Market, by Test Type– Revenue and forecast to 2028 (USD Million)

Table 89.China: Sepsis Diagnostics Market, by Pathogen – Revenue and forecast to 2028 (USD Million)

Table 90.China: Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 91.Japan: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 92.Japan: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 93.Japan: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 94.Japan: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 95.Japan: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 96.Japan: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 97.Japan: Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 98.India: Sepsis Diagnostics Market, By Product– Revenue and Forecast to 2028(USD Million)

Table 99.India: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 100.India: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 101.India: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 102.India: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 103.India: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 104.India: Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 105.Australia: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 106.Australia: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 107.Australia: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 108.Australia: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 109.Australia: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 110.Australia: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 111.Australia: Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 112.South Korea: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 113.South Korea: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 114.South Korea: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 115.South Korea: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 116.South Korea: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 117.South Korea: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 118.South Korea: Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 119.Rest of Asia Pacific: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 120.Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology– Revenue and Forecast to 2028 (USD Million)

Table 121.Rest of Asia Pacific: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 122.Rest of Asia Pacific: Sepsis Diagnostics Market, By Method– Revenue and Forecast to 2028 (USD Million)

Table 123.Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type– Revenue and Forecast to 2028 (USD Million)

Table 124.Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen– Revenue and Forecast to 2028 (USD Million)

Table 125.Rest of Asia Pacific: Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 126.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 127.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 128.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 129.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 130.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 131.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 132.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 133.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 134.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 135.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 136.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 137.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 138.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 139.UAE: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 140.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 141.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 142.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 143.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 144.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 145.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 146.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 147.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 148.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 149.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 150.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 151.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 152.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 153.South Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 154.Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 155.Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 156.Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 157.Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 158.Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 159.Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 160.Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 161.South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 162.South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 163.South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 164.South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 165.South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 166.South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 167.South and Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 168.Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 169.Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 170.Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 171.Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 172.Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 173.Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 174.Brazil: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 175.Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 176.Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 177.Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 178.Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 179.Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 180.Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 181.Argentina: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 182.Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 183.Rest of South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 184.Rest of South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 185.Rest of South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 186.Rest of South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 187.Rest of South and Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 188.Rest of South and Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 189.Organic Developments in the Sepsis Diagnostics Market

Table 190.Inorganic Developments in the Sepsis Diagnostics Market

Table 191.Glossary of Terms

LIST OF FIGURES

Figure 1.Sepsis Diagnostics Market Segmentation

Figure 2.Sepsis Diagnostics Market, By Region

Figure 3.Global Sepsis Diagnostics Market Overview

Figure 4.Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market

Figure 5.Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.Sepsis Diagnostics Market, by Geography (US$ Million)

Figure 7.Global Sepsis Diagnostics Market- Leading Country Markets (US$ Million)

Figure 8.Global Sepsis Diagnostics Market, Industry Landscape

Figure 9.North America: PEST Analysis

Figure 10.Europe: PEST Analysis

Figure 11.Asia Pacific: PEST Analysis

Figure 12.Middle East And Africa: PEST Analysis

Figure 13.South And Central America: PEST Analysis

Figure 14.Experts Opinion

Figure 15.Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints

Figure 16.Global Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 17.Global Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 18.Market Positioning of Key Players in Global Sepsis Diagnostics Market

Figure 19.Global Sepsis Diagnostics market – Market Potential Analysis, By Region

Figure 20.Global Sepsis Diagnostics market – Comparative Company Analysis

Figure 21.Global Sepsis Diagnostics Market – Growth Strategy Analysis

Figure 22.Market Share Analysis of Key Players in Global Sepsis Diagnostics Market

Figure 23.Global Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)

Figure 24.Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.Global Sepsis Diagnostics Market Share by Application - 2021 & 2028 (%)

Figure 29.Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30.Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31.Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32.Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 33.Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34.Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 35.Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 36.Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 37.Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 38.Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 39.Global Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)

Figure 40.Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 41.Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 42.Global Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)

Figure 43.Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 44.Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 45.Global Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)

Figure 46.Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 47.Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 48.Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 49.Global Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)

Figure 50.Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 51.Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 52.Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 53.North America: Sepsis Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 54.North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 55.North America: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 56.US: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 57.Canada: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 58.Mexico: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 59.Europe: Sepsis Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 60.Europe: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 61.Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 62.Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 63.France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 64.UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 65.Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 66.Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 67.Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 68.Asia Pacific: Sepsis Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 69.Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 70.Asia Pacific: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 71.China: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 72.Japan: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 73.India: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 74.Australia: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 75.South Korea: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 76.Rest of Asia Pacific: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 77.Middle East & Africa: Sepsis Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 78.Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 79.Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

Figure 80.UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 81.Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 82.South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 83.Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 84.South and Central America Sepsis Diagnostics Market Revenue Overview, by Key Country, 2021 (US$ Million)

Figure 85.South and Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 86.South and Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

Figure 87.Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 88.Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 89.Rest of South and Central America: Sepsis Diagnostics Market– Revenue and Forecast to 2028 (US$ Mn)

Figure 90.Impact of COVID-19 Pandemic in North American Country Markets

Figure 91.Impact of COVID-19 Pandemic in European Country Markets

Figure 92.Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 93.Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 94.Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets

Figure 95.Growth Strategies in the Sepsis Diagnostics Market (%)

The List of Companies - Sepsis Diagnostics Market 
  1. Abbott
  2. F. Hoffmann-La Roche Ltd.     
  3. Immunexpress Inc.    
  4. BD     
  5. Danaher          
  6. Luminex Corporation                
  7. Thermo Fisher Scientific Inc.                  
  8. bioMerieux SA.            
  9. T2 Biosystems, Inc.     
  10. Axis-Shield Diagnostics Ltd.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the sepsis diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPHE100001391
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount